0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

Showing articles whose micro-themes are very close to: #Vaccine development
  1. Development of Pandemic Vaccines: ERVEBO Case Study (pmc.ncbi.nlm.nih.gov) | 17d ago
  2. UK scientists develop novel Ebola vaccine; Serum Institute of India to mass-produce (youtube.com) | 13d ago
  3. Review of Ebola Virus Outbreak Epidemiology and Treatment Advances (cureus.com) | 14d ago
  4. Report on Accelerating Ebola Vaccine Development: 2015 Recommendations from Wellcome Trust and CIDRAP (cidrap.umn.edu) | 4146d ago
  5. Coalition for Epidemic Preparedness Innovations (CEPI) updates Ebola vaccine development progress (youtube.com) | 14d ago
  6. WHO Raises Ebola Risk to Very High in DR Congo for Bundibugyo Species (bbc.co.uk) | 18d ago
  7. WHO reports 906 suspected Ebola cases and 223 deaths from Bundibugyo strain in DRC (indiatoday.in) | 11d ago
  8. Bundibugyo Ebola Outbreak in Eastern DRC: No Approved Vaccines, Reliance on Experimental Treatments (devdiscourse.com) | 11d ago
  9. Factbox: Bundibugyo Ebola vaccines and treatments in development (devdiscourse.com) | 18d ago
  10. CEPI's role in developing vaccines for epidemic-prone infectious diseases (law.berkeley.edu) | 15d ago
  11. WHO recommends Ebola treatments and vaccines be tested only in clinical trials (ca.news.yahoo.com) | 12d ago
  12. Ebola outbreak in DR Congo: Reflections from West African survivor highlight need for speed, community trust, and vaccine development for Bundibugyo species (bbc.co.uk) | 18d ago
  13. Ebola vaccines: Overview of Ervebo, Zabdeno, and Mvabea (en.wikipedia.org) | 14d ago
  14. Ebola virus disease: an update on post-exposure prophylaxis – PMC (pmc.ncbi.nlm.nih.gov) | 14d ago
  15. Ebola Virus Disease: Transmission, Symptoms, Treatment, and Current Outbreak in DRC and Uganda (May 2026) (concern.net) | 15d ago
  16. rVSV-ZEBOV (Ervebo) Vaccine: Comprehensive Overview (en.wikipedia.org) | 14d ago
  17. WHO Technical Advisory Group Prioritizes Vaccine Candidates for Bundibugyo Virus Disease in DRC and Uganda (who.int) | 12d ago
  18. Ebola Outbreak Update: DRC and Uganda, 18 May 2026 (tools.cdc.gov) | 22d ago
  19. Use of Ebola Vaccines — Worldwide, 2021–2023 | MMWR - CDC (cdc.gov) | 17d ago
  20. Bundibugyo virus causing deadly Ebola outbreak in DRC and Uganda has no licensed vaccine (gavi.org) | 18d ago
  21. Ebola outbreak in DRC and Uganda: 116 deaths, 300 cases, no approved vaccine for Bundibugyo strain (pbs.org) | 22d ago
  22. Bundibugyo Outbreak Highlights Need for Broad-Spectrum Ebola Vaccines (bioworld.com) | 19d ago
  23. Ebola Disease – World Health Organization Fact Sheet (who.int) | 16d ago
  24. WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 15d ago
  25. WHO emergency guidance on licensed Ebola vaccine use during Bundibugyo virus disease outbreaks (who.int) | 12d ago
  26. Gavi allocates $50 million to Bundibugyo ebolavirus vaccine development and outbreak response (gavi.org) | 11d ago
  27. Vaccine and antiviral R&D underway for rare Bundibugyo Ebola outbreak (bioworld.com) | 14d ago
  28. Search Begins for Vaccine as Bundibugyo Ebola Deaths Rise (pharmaphorum.com) | 19d ago
  29. WHO considers experimental vaccines as Ebola cases exceed 500 in DRC (theguardian.com) | 15d ago
  30. WHO: Bundibugyo Ebola vaccine months away from human trials (nbcnews.com) | 20d ago
  31. Ring Vaccination with rVSV-ZEBOV-GP Significantly Reduces Ebola Incidence (2minutemedicine.com) | 17d ago
  32. WHO Elevates Ebola Risk Assessment to 'Very High' for Democratic Republic of the Congo (youtube.com) | 13d ago
  33. WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 14d ago
  34. FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment (fda.gov) | 14d ago
  35. Africa CDC: No Approved Vaccine for Ebola-Sudan Strain, Trial Underway (facebook.com) | 17d ago
  36. Bundibugyo Ebola virus outbreak in DRC and Uganda: no approved countermeasures (wellcome.org) | 11d ago
  37. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 17d ago
Showing page 1 of 1 (37 total results)
← Prev Next →